Quick answer
How is Melanotan II (MT-2) used as a research tool? MT-2 is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. In the melanocortin literature it serves as a stable, potent, non-selective reference agonist against which other ligands are compared at the five melanocortin receptors. This handbook is organized around the bench: what the structure implies for handling, how to build a receptor-panel experiment, which controls to include and what to check on the material. It is supplied for laboratory research use only.
Why a handbook rather than a profile
The Melanotan II research overview covers history and findings. A different question comes up at the bench: given a vial of MT-2, how is a clean melanocortin experiment built around it? The answer depends on what the molecule is, what it activates, and what could make a result misleading. Each section below addresses one of those.
The MT-2 product page lists the formula C50H69N15O9, the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, a 10 mg size, ≥98% HPLC purity, lyophilized powder and a sealed clear glass vial, with storage at 2-8 °C or −20 °C for long-term.
Structure and what it implies
| Feature | Detail | Bench consequence |
|---|---|---|
| N-terminal acetyl | Ac cap | Removes the N-terminal charge; blocks aminopeptidase attack |
| Nle at position 1 | Norleucine in place of methionine | Avoids the oxidation-prone thioether of Met |
| Lactam ring | Asp side chain to Lys side chain amide bond | Constrains the peptide; ring closure must be confirmed |
| D-Phe | D-amino acid in the receptor-recognition core | Associated with higher potency and protease stability |
| C-terminal amide | -NH2 | Neutral C-terminus; this is the feature that differs from PT-141, whose C-terminus is a free acid |
The cyclic design came from work on superpotent cyclic α-melanotropins in the late 1980s, which designed cyclic α-melanotropins described as superpotent.[1] The lactam bridge and the D-Phe in the His-Phe-Arg-Trp message region are the features of MT-2 usually credited with its potency and stability. The average molecular weight from the formula is about 1,024 g/mol. Because ring closure alters the mass by loss of water relative to the linear precursor, mass spectrometry is a meaningful identity check, although it cannot alone prove that the ring formed between the intended side chains.
The five melanocortin receptors in one paragraph
The melanocortin receptors MC1R to MC5R are G protein-coupled receptors; the family was cloned in the early 1990s, with MC1R and MC2R reported in 1992.[2] Reviews describe the system's physiological functions, which range from pigmentation through energy homeostasis to exocrine function,[3] and discuss the structure and regulation of the receptors.[4][5] For a laboratory the useful points are that the subtypes are expressed in different tissues and cell lines, that they couple mainly to cAMP signaling, and that ligand selectivity across subtypes is the main thing separating one melanocortin tool from another.
Using MT-2 as the reference agonist in a receptor panel
The reason MT-2 appears so often in melanocortin papers is its pharmacological profile: it is a potent agonist at several subtypes. A review of the melanocortin peptide field describes the historical development of the melanotan analogs and their place in the field.[6] In a panel experiment, MT-2 anchors the dose-response curve, and a new ligand is judged by where its curve sits relative to it. A subtype-selectivity study of cyclic MSH analogs shows the approach: cyclic analogs substituted at position 7 were profiled across receptor subtypes to map selectivity.[7]
A panel design follows a fixed pattern:
- Cell lines with defined receptor expression, preferably stably transfected cells expressing one subtype each, plus a parental line as negative control.
- A cAMP readout with a defined incubation time and a phosphodiesterase inhibitor stated in the methods.
- A full MT-2 concentration series on every plate, so that plates can be normalized to the same reference maximum.
- A native α-MSH arm for comparison with the endogenous agonist.
- An antagonist arm to show that the response is receptor-mediated.
- A forskolin arm to define the ceiling for cAMP generation independent of the receptor.
Panel layout at a glance
| Arm | Purpose | What a failure would mean |
|---|---|---|
| Parental cell line + MT-2 | Negative control | A cAMP rise means endogenous receptors or non-receptor effects |
| Receptor-expressing line + vehicle | Baseline | High baseline means constitutive activity or contamination |
| Receptor-expressing line + MT-2 series | Reference curve | Flat curve means a material, cell or assay problem |
| Receptor-expressing line + native α-MSH | Endogenous comparator | Large deviation from the literature suggests an assay problem |
| Receptor-expressing line + antagonist, then MT-2 | Receptor dependence | No shift means the response is not receptor-mediated |
| Forskolin | Assay ceiling | Low ceiling means cells are unhealthy or the readout is saturated |
Concentration arithmetic, formula only
Peptide stocks should be made on a molar basis. The formula is concentration (mol/L) = [mass (mg) ÷ molecular weight (g/mol)] ÷ volume (mL) × 1,000 when mass is in mg and volume in mL. With the formula weight of about 1,024 g/mol, a dilution series can be planned in the calculator. Two corrections are worth making: the vial's net peptide content is lower than its label mass because counterions and water contribute, and a lyophilized peptide takes up water from air, so stocks of unknown water content are best verified by a spectrophotometric or amino-acid analysis if tight dose-response comparisons are planned. The tryptophan residue gives the peptide a UV absorbance near 280 nm that can be used for a rough concentration check.
Material checks before the first experiment
A reference agonist is only useful if it is what the label says. Four checks matter. Identity by mass matches the calculated value for C50H69N15O9. Ring closure is supported by the intact mass together with a retention time consistent with a cyclic species. Purity is reported by HPLC; read the chromatogram, not only the percentage, as covered in Melanotan II purity testing. Finally the lot is traceable: record the lot number and date, and compare with the COA library where a lot is published. For guidance on reading the fields see how to read a COA.
One confusion to avoid: MT-2 and PT-141 differ only at the C-terminus, so their masses differ by about one unit (the amide versus the free acid), and a mis-labeled vial would be hard to spot by retention time alone. The two should be stored apart and identified by mass. The comparison is in PT-141 vs melanotan II.
Storage, handling and research-use statement
Keep lyophilized material refrigerated at 2-8 °C, or at −20 °C for long-term storage, protected from heat, moisture and light, per the product page. Reconstitute in the volume a session needs, divide leftovers into single-use portions and avoid repeated freeze-thaw. All material discussed here is supplied for laboratory research use only; not for human or animal consumption, and not a drug, food or cosmetic.
Related reading
- Melanotan II research overview: the pillar guide
- MT-2 (Melanotan II) product page: size, purity and storage line
- PT-141 vs melanotan II: research comparison
- Melanotan II purity testing
- What is melanotan 1?
- KPV vs α-MSH: melanocortin comparison
- How to read a COA
- Browse all research compounds
Frequently asked questions
What is Melanotan II?
A synthetic cyclic heptapeptide analog of α-MSH, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, used in the laboratory as a potent, non-selective melanocortin reference agonist.
Why is MT-2 used as a reference?
It is stable and potent relative to the native hormone, a result of the lactam ring and D-Phe design from the late 1980s.[1]
How many melanocortin receptors are there?
Five, MC1R to MC5R, all G protein-coupled receptors; MC1R and MC2R were cloned in 1992.[2][3]
What readout is common in receptor panels?
cAMP accumulation in cells expressing a single receptor subtype, with a parental line and forskolin as controls.
What is the molecular formula and weight?
C50H69N15O9, about 1,024 g/mol, as listed on the product page.
How does MT-2 differ from PT-141?
At the C-terminus: MT-2 has an amide, PT-141 a free carboxylic acid.
Why is ring closure important to check?
The lactam ring is what constrains the peptide, so material that failed to cyclize behaves differently; mass and retention support closure.
How should a stock be calculated?
Mass in mg divided by molecular weight in g/mol gives mmol; divide by volume in mL. The calculator does it, and net peptide content should be considered.
How is MT-2 stored?
2-8 °C, or −20 °C for long-term, protected from heat, moisture and light.
Is MT-2 intended for people or animals?
No. It is supplied for laboratory research use only; not for human or animal consumption.
Related reading: Melanotan II to PT-141: History of a Peptide Lineage.
References
- Al-Obeidi F, et al. Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations. J Am Chem Soc. 1989. doi:10.1021/ja00191a044
- Mountjoy KG, et al. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992. doi:10.1126/science.1325670 PMID: 1325670
- Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 2006. doi:10.1210/er.2006-0034 PMID: 17077189
- Abdel-Malek ZA. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci. 2001. doi:10.1007/pl00000868 PMID: 11315190
- Yang Y. Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol. 2011. doi:10.1016/j.ejphar.2010.12.020 PMID: 21208602
- Hadley ME, et al. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006. doi:10.1016/j.peptides.2005.01.029 PMID: 16412534
- Schiöth HB, et al. Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides. 1997. doi:10.1016/s0196-9781(97)00079-x PMID: 9357059
